Aloracetam
Aloracetam is a drug described as a nootropic which is closely related to, but technically not of, the racetam family of compounds. It was studied by Aventis for the treatment of Alzheimer's disease, but was never marketed.
Aloracetam is a drug described as a nootropic which is closely related to, but technically not of, the racetam family of compounds. It was studied by Aventis for the treatment of Alzheimer's disease, but was never marketed.